Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06039917

Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,460 (estimated)
Sponsor
Renmin Hospital of Wuhan University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.

Detailed description

The adherence of doctors to published surveillance guidelines for patients with gastric premalignant lesions varies greatly, and surveillance of patients is critical but time-consuming. In previous studies we developed an automatic surveillance (AS) system to accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients in time. In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.

Conditions

Interventions

TypeNameDescription
OTHERAI based automatic surveillance (AS) system (ENDOANGEL-AS)An automatic surveillance (AS) system accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times.
OTHERManually remind the patientsMedical staff remind patients to review manually.

Timeline

Start date
2023-09-10
Primary completion
2028-12-31
Completion
2029-12-31
First posted
2023-09-15
Last updated
2024-11-04

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06039917. Inclusion in this directory is not an endorsement.